Simultaneous EUS-guided portosystemic pressure measurement and liver biopsy sampling correlate with clinically meaningful outcomes

被引:43
作者
Hajifathalian, Kaveh [1 ]
Westerveld, Donevan [1 ]
Kaplan, Alyson [1 ]
Dawod, Enad [1 ]
Herr, Andrea [1 ]
Ianelli, Mallory [1 ]
Saggese, Allysa [1 ]
Kumar, Sonal [1 ]
Fortune, Brett E. [1 ]
Sharaiha, Reem Z. [1 ]
机构
[1] New York Presbyterian Hosp, Div Gastroenterol & Hepatol, Weill Cornell Med, New York, NY USA
关键词
SIMPLE NONINVASIVE INDEX; GRADIENT MEASUREMENT; SIGNIFICANT FIBROSIS; REDUCTION; CIRRHOSIS; PREDICT; SYSTEM;
D O I
10.1016/j.gie.2021.11.037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: The measurement of the portosystemic pressure gradient (PSG) in patients with advanced liver disease is helpful to assess the severity of portal hypertension (PH) and predict adverse clinical outcomes. EUS-guided PSG (EUS-PSG) measurement is a novel tool to assess PSG in all patients with advanced liver disease. We sought to assess the safety, feasibility, and technical success of simultaneous EUS-PSG measure-ment and EUS-guided liver biopsy sampling using a single-center experience. Methods: Patients with suspected liver disease or cirrhosis were enrolled prospectively from 2020 to 2021. EUS-PSG was measured by calculating the difference between the mean portal pressure and the mean hepatic vein pressure. PH was defined as PSG >5 mm Hg and clinically significant PH as PSG >= 10 mm Hg. The primary out-comes were procedural technical success rate and correlation of EUS-PSG with fibrosis stage obtained from con-current EUS-guided liver biopsy sampling and the correlation of EUS-PSG with patients' imaging, clinical, and laboratory findings. The secondary outcome was occurrence of procedural adverse events (AEs). Results: Twenty-four patients were included in the study. PSG measurement and EUS-guided liver biopsy sam-pling were successful in 23 patients (technical success rate of 96%) and 24 patients (100% success), respectively. Analysis revealed a significant association between both PSG and liver stiffness measured on transient elastogra-phy (P = .011) and fibrosis-4 score (P = .026). No significant correlation was found between the fibrosis stage on histology and measured PSG (P = .559). One mild AE of abdominal pain was noted. Additionally, EUS-PSG was predictive of clinically evident PH. Conclusions: Simultaneous EUS-PSG measurement and EUS-guided liver biopsy sampling were both feasible and safe and correlated with clinically evident PH and noninvasive markers of fibrosis.
引用
收藏
页码:703 / 710
页数:8
相关论文
共 19 条
[1]   The management of antithrombotic agents for patients undergoing GI endoscopy [J].
Acosta, Ruben D. ;
Abraham, Neena S. ;
Chandrasekhara, Vinay ;
Chathadi, Krishnavel V. ;
Early, Dayna S. ;
Eloubeidi, Mohamad A. ;
Evans, John A. ;
Faulx, Ashley L. ;
Fisher, Deborah A. ;
Fonkalsrud, Lisa ;
Hwang, Joo Ha ;
Khashab, Mouen A. ;
Lightdale, Jenifer R. ;
Muthusamy, V. Raman ;
Pasha, Shabana F. ;
Saltzman, John R. ;
Shaukat, Aasma ;
Shergill, Amandeep K. ;
Wang, Amy ;
Cash, Brooks D. ;
DeWitt, John M. .
GASTROINTESTINAL ENDOSCOPY, 2016, 83 (01) :3-16
[2]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[3]  
Berzigotti A, 2013, EXPERT REV GASTROENT, V7, P141, DOI [10.1586/egh.12.83, 10.1586/EGH.12.83]
[4]   The clinical use of HVPG measurements in chronic liver disease [J].
Bosch, Jaime ;
Abraldes, Juan G. ;
Berzigotti, Annalisa ;
Carlos Garcia-Pagan, Juan .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (10) :573-582
[5]   A lexicon for endoscopic adverse events: report of an ASGE workshop [J].
Cotton, Peter B. ;
Eisen, Glenn M. ;
Aabakken, Lars ;
Baron, Todd H. ;
Hutter, Matt M. ;
Jacobson, Brian C. ;
Mergener, Klaus ;
Nemcek, Albert, Jr. ;
Petersen, Bret T. ;
Petrini, John L. ;
Pike, Irving M. ;
Rabeneck, Linda ;
Romagnuolo, Joseph ;
Vargo, John J. .
GASTROINTESTINAL ENDOSCOPY, 2010, 71 (03) :446-454
[6]   Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: A systematic review [J].
D'Amico, Gennaro ;
Garcia-Pagan, Juan Carlos ;
Luca, Angelo ;
Bosch, Jaime .
GASTROENTEROLOGY, 2006, 131 (05) :1611-1624
[7]   Endoscopic ultrasound-guided portal-systemic pressure gradient measurement [J].
Fujii-Lau, Larissa L. ;
Leise, Michael D. ;
Kamath, Patrick S. ;
Gleeson, Ferga C. ;
Levy, Michael J. .
ENDOSCOPY, 2014, 46 :E654-E656
[8]   EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study [J].
Huang, Jason Y. ;
Samarasena, Jason B. ;
Tsujino, Takeshi ;
Lee, John ;
Hu, Ke-Qin ;
McLaren, Christine E. ;
Chen, Wen-Pin ;
Chang, Kenneth J. .
GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) :996-1001
[9]  
JALAN R, 1995, AM J GASTROENTEROL, V90, P1994
[10]   Design and validation of a histological scoring system for nonalcoholic fatty liver disease [J].
Kleiner, DE ;
Brunt, EM ;
Van Natta, M ;
Behling, C ;
Contos, MJ ;
Cummings, OW ;
Ferrell, LD ;
Liu, YC ;
Torbenson, MS ;
Unalp-Arida, A ;
Yeh, M ;
McCullough, AJ ;
Sanyal, AJ .
HEPATOLOGY, 2005, 41 (06) :1313-1321